TY - JOUR
T1 - Gamma knife radiosurgery for idiopathic and secondary trigeminal neuralgia
AU - Jin Woo Chang, Woo Chang
AU - Jong Hee Chang, Hee Chang
AU - Yong Gou Park, Gou Park
AU - Sang Sup Chung, Sup Chung
PY - 2000
Y1 - 2000
N2 - Object. The aim of this study was to identify pain relief and treatment morbidity following gamma knife radiosurgery (GKS) for idiopathic and secondary trigeminal neuralgia. Methods. Between May 1992 and December 1999, 15 patients with idiopathic trigeminal neuralgia and 38 patients with secondary trigeminal neuralgia were treated with GKS. Pain improvement was achieved in 13 of the patients with idiopathic pain (pain response rate 86.7%). Seven patients were pain free and another six experienced pain reduction. There were no serious complications; however, two patients suffered a mild facial sensory change 8 months and 9 months, respectively, after GKS. The patients with secondary trigeminal neuralgia were divided into two groups (Group I, 32 patients in whom the trigeminal root entry zone [REZ] near the tumor could not be visualized; and Group II, six patients in whom the trigeminal REZ near the tumor or brainstem lesion could be visualized). In Group I, the pain subsided completely in eight patients and was reduced in seven (pain response rate 46.9%). In Group II, the pain subsided completely in one patient at 2.8 months and was reduced in three patients at a mean follow up of 0.8 months (range 0.6-1 month) after GKS. The pain response rate was 66.7%. Conclusions. The authors believe that GKS is an effective treatment modalities for idiopathic and secondary trigeminal neuralgia, particularly in patients with inoperable lesions.
AB - Object. The aim of this study was to identify pain relief and treatment morbidity following gamma knife radiosurgery (GKS) for idiopathic and secondary trigeminal neuralgia. Methods. Between May 1992 and December 1999, 15 patients with idiopathic trigeminal neuralgia and 38 patients with secondary trigeminal neuralgia were treated with GKS. Pain improvement was achieved in 13 of the patients with idiopathic pain (pain response rate 86.7%). Seven patients were pain free and another six experienced pain reduction. There were no serious complications; however, two patients suffered a mild facial sensory change 8 months and 9 months, respectively, after GKS. The patients with secondary trigeminal neuralgia were divided into two groups (Group I, 32 patients in whom the trigeminal root entry zone [REZ] near the tumor could not be visualized; and Group II, six patients in whom the trigeminal REZ near the tumor or brainstem lesion could be visualized). In Group I, the pain subsided completely in eight patients and was reduced in seven (pain response rate 46.9%). In Group II, the pain subsided completely in one patient at 2.8 months and was reduced in three patients at a mean follow up of 0.8 months (range 0.6-1 month) after GKS. The pain response rate was 66.7%. Conclusions. The authors believe that GKS is an effective treatment modalities for idiopathic and secondary trigeminal neuralgia, particularly in patients with inoperable lesions.
UR - http://www.scopus.com/inward/record.url?scp=0034433321&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0034433321&partnerID=8YFLogxK
U2 - 10.3171/jns.2000.93.supplement_3.0147
DO - 10.3171/jns.2000.93.supplement_3.0147
M3 - Article
C2 - 11143233
AN - SCOPUS:0034433321
VL - 93
SP - 147
EP - 151
JO - Journal of Neurosurgery
JF - Journal of Neurosurgery
SN - 0022-3085
IS - SUPPL. 3
ER -